Limited coverage criteria – linezolid

Last updated on March 19, 2025

 

Return to Special Authority drug list 

Generic name

linezolid

Strength & form

600 mg tabet

Special Authority criteria

Approval period

Treatment of vancomycin-resistant enterococcus infections

OR

Treatment of methicillin-resistant staphylococcus aureus in individuals who are unresponsive to or intolerant of parenteral vancomycin

Maximum 30 days

Practitioner exemptions

  • Infectious disease specialists

Special notes

  • None

Special Authority request form(s)